CANbridge Pharmaceuticals Inc. (1228.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 1.14B |
| Enterprise Value | 1.09B |
| P/E Ratio | 38.15 |
| PEG Ratio | 0.06 |
| Price/Sales Ratio | 15.37 |
| Price/Book Ratio | -2.52 |
| Enterprise/Revenue | 14.36 |
| Enterprise/EBITDA | -9.01 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | 0.3 |
| Operating Margin | -1.85 |
AD
Management Effectiveness
| Return On Assets | 0.09 |
| Return On Equity | -0.04 |
Income Statement
| Revenue | 49.98M |
| Revenue/Share | 0.1 |
| Gross Profit | 36.56M |
| EBITDA | -78.98M |
| Net Income | 14.82M |
| Diluted EPS | 0.03 |
Balance Sheet
| Total Cash | 66.63M |
| Total Cash/Share | 0.14 |
| Total Debt | 16.08M |
| Total Debt/Equity | -0.05 |
| Current Ratio | 0.24 |
| Book Value Per Share | -0.72 |
Price History
| 52-Week Change | 145.88 |
| 52-Week High | 3.5 |
| 52-Week Low | 0.67 |
| Moving Average 50 Days | 2.04 |
| Moving Average 200 Days | 2.33 |
Statistics
| Average Volume | 649,446 |
| Shares Outstanding | 424.84M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
